Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial

作者：Michael Trauner, Cynthia Levy, Atsushi Tanaka, Zachary Goodman, Douglas Thorburn, Deepak Joshi, Kimmo Salminen, Kidist Yimam, Hiroyuki Isayama, Aldo J. Montaño‐Loza, Stephen H. Caldwell, Mark Danta, Martti Färkkilâ, Juan F. Gallegos‐Orozco, Stuart C. Gordon, Holger Hinrichsen, Pietro Invernizzi, Raj Vuppalanchi, Kaiyi Zhu, Jun Xu, Xiangyu Liu, Xiaomin Lu, Gerald Crans, Shahla Bolbolan, Lisa Boyette, Muhsen Al-ani, William Barchuk, Timothy R. Watkins, Mark C. Genovese, Christopher L. Bowlus · 发表于：˜The œLancet. Gastroenterology & hepatology · 年份：2025 · DOI：10.1016/s2468-1253(25)00208-0 · 被引用次数：11 · 研究领域：Liver Diseases and Immunity、Gallbladder and Bile Duct Disorders、Pediatric Hepatobiliary Diseases and Treatments